204 related articles for article (PubMed ID: 38812523)
1. The cholera toxin B subunit induces trained immunity in dendritic cells and promotes CD8 T cell antitumor immunity.
Tepale-Segura A; Gajón JA; Muñoz-Cruz S; Castro-Escamilla O; Bonifaz LC
Front Immunol; 2024; 15():1362289. PubMed ID: 38812523
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
[TBL] [Abstract][Full Text] [Related]
3. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.
Antonio-Herrera L; Badillo-Godinez O; Medina-Contreras O; Tepale-Segura A; García-Lozano A; Gutierrez-Xicotencatl L; Soldevila G; Esquivel-Guadarrama FR; Idoyaga J; Bonifaz LC
Front Immunol; 2018; 9():2212. PubMed ID: 30319653
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
5. Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.
Odumosu O; Payne K; Baez I; Jutzy J; Wall N; Langridge W
Immunobiology; 2011 Apr; 216(4):447-56. PubMed ID: 20956025
[TBL] [Abstract][Full Text] [Related]
6. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models.
Onyshchenko K; Luo R; Rao X; Zhang X; Gaedicke S; Grosu AL; Firat E; Niedermann G
Theranostics; 2024; 14(6):2573-2588. PubMed ID: 38646638
[No Abstract] [Full Text] [Related]
8. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
Lycke N
Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
[TBL] [Abstract][Full Text] [Related]
9. LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells.
Kim NS; Torrez T; Langridge W
Cell Immunol; 2019 Apr; 338():32-42. PubMed ID: 30910218
[TBL] [Abstract][Full Text] [Related]
10. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA.
Wakabayashi A; Shimizu M; Shinya E; Takahashi H
Cell Death Dis; 2018 May; 9(6):631. PubMed ID: 29795370
[TBL] [Abstract][Full Text] [Related]
12. The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGF-β.
Gloudemans AK; Plantinga M; Guilliams M; Willart MA; Ozir-Fazalalikhan A; van der Ham A; Boon L; Harris NL; Hammad H; Hoogsteden HC; Yazdanbakhsh M; Hendriks RW; Lambrecht BN; Smits HH
PLoS One; 2013; 8(3):e59822. PubMed ID: 23527272
[TBL] [Abstract][Full Text] [Related]
13. Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function.
Odumosu O; Nicholas D; Payne K; Langridge W
Vaccine; 2011 Oct; 29(46):8451-8. PubMed ID: 21807047
[TBL] [Abstract][Full Text] [Related]
14. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
15. Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8
Darling R; Senapati S; Christiansen J; Liu L; Ramer-Tait AE; Narasimhan B; Wannemuehler M
Int J Nanomedicine; 2020; 15():6579-6592. PubMed ID: 32982219
[TBL] [Abstract][Full Text] [Related]
16. Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.
Mbongue JC; Nicholas DA; Zhang K; Kim NS; Hamilton BN; Larios M; Zhang G; Umezawa K; Firek AF; Langridge WH
PLoS One; 2015; 10(2):e0118562. PubMed ID: 25714914
[TBL] [Abstract][Full Text] [Related]
17. Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity.
Isomura I; Yasuda Y; Tsujimura K; Takahashi T; Tochikubo K; Morita A
Microbiol Immunol; 2005; 49(1):79-87. PubMed ID: 15665457
[TBL] [Abstract][Full Text] [Related]
18. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.
Eriksson K; Fredriksson M; Nordström I; Holmgren J
Infect Immun; 2003 Apr; 71(4):1740-7. PubMed ID: 12654787
[TBL] [Abstract][Full Text] [Related]
19. Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responses.
Harjunpää H; Somermäki R; Saldo Rubio G; Fusciello M; Feola S; Faisal I; Nieminen AI; Wang L; Llort Asens M; Zhao H; Eriksson O; Cerullo V; Fagerholm SC
Oncoimmunology; 2024; 13(1):2369373. PubMed ID: 38915784
[TBL] [Abstract][Full Text] [Related]
20. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
